The impact of early nutritional and immune status assessment on all-cause mortality in patients with intracerebral hemorrhage in the intensive care unit: a retrospective study - Scorecard - MDSpire

The impact of early nutritional and immune status assessment on all-cause mortality in patients with intracerebral hemorrhage in the intensive care unit: a retrospective study

  • By

  • Jun Chen

  • Hui-Zhen Chen

  • Jun-Feng Lu

  • Yi-Yi Wu

  • Jian-Ting Gao

  • July 7, 2026

  • 0 min

Share

Clinical Scorecard: Evaluating the Role of Early Nutritional and Immune Status Assessment on Overall Mortality in Intensive Care Unit Patients with Intracerebral Hemorrhage: A Retrospective Analysis

At a Glance

CategoryDetail
ConditionIntracerebral Hemorrhage (ICH)
Key MechanismsNutritional and immune status impact neurological outcomes and mortality.
Target PopulationPatients with intracerebral hemorrhage in intensive care units.
Care SettingIntensive Care Unit (ICU)

Key Highlights

  • 30-day, 90-day, and 365-day mortality rates for ICH patients were 29.08%, 34.49%, and 41.84%, respectively.
  • The HALP score is a composite indicator integrating nutritional, immune, and thrombotic-inflammatory pathways.
  • Lower HALP scores correlate with higher mortality rates in ICH patients.
  • A risk prediction nomogram based on the HALP score was developed and validated.
  • The nomogram achieved an AUROC of 0.825 in the internal cohort.

Guideline-Based Recommendations

Diagnosis

  • Assess HALP score for prognostic evaluation in ICH patients.

Management

  • Utilize nutritional and immune status assessments in treatment planning for ICH patients.

Monitoring & Follow-up

  • Monitor HALP score to identify high-risk ICH patients.

Risks

  • Patients with HALP < 16.87 exhibit significantly higher mortality.

Patient & Prescribing Data

Adult patients with primary diagnosis of cerebral hemorrhage.

Nutritional and immune status should be prioritized in management strategies.

Clinical Best Practices

  • Incorporate HALP score assessment in routine evaluations of ICH patients.
  • Implement risk stratification tools to guide clinical decision-making.

Related Resources & Content

Original Source(s)

Related Content